Bionano Genomics
BNGO
11 hedge funds and large institutions have $7.14M invested in Bionano Genomics in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
38% more funds holding
Funds holding: 8 → 11 (+3)
0.11% less ownership
Funds ownership: 0.15% → 0.03% (-0.11%)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
89% less capital invested
Capital invested by funds: $67M → $7.14M (-$59.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$1.63M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$498K |
| 3 |
Millennium Management
New York
|
+$323K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$27.9K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$47.2M |
| 2 |
Walleye Trading
New York
|
-$756K |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$104K |
| 4 |
SCM
Sio Capital Management
New York
|
-$27.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCM
1
Sio Capital Management
New York
| $4.85M | -$27.9K | -7 | -0.3% |
|
|
MIM
2
Monashee Investment Management
Boston,
Massachusetts
| $1.29M | +$1.63M | +410 | New |
|
|
WVP
3
Worth Venture Partners
Fort Lee,
New Jersey
| $417K | +$498K | +125 | +1,563% |
|
|
4
Millennium Management
New York
| $254K | +$323K | +81 | New |
|
|
PCM
5
Perkins Capital Management
Wayzata,
Minnesota
| $176K | -$104K | -26 | -32% |
|
|
6
Federated Hermes
Pittsburgh,
Pennsylvania
| $78K | -$47.2M | -11,840 | -100% |
|
7
Victory Capital Management
San Antonio,
Texas
| $43K | – | – | – |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $21K | +$27.9K | +7 | New |
|
9
BlackRock
New York
| $4K | +$3.98K | +1 | New |
|
10
Morgan Stanley
New York
| $2K | – | – | – |
|
|
11
Acadian Asset Management
Boston,
Massachusetts
| $2K | +$3.98K | +1 | New |
|
|
12
Walleye Trading
New York
| – | -$756K | -158 | Closed |
|
BNGO Hedge Fund Activity: Q4 2018 in Review
11 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q4 2018, worth a combined $7.14M — down 89% from $67M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BNGO positions and 1 closed out — a net gain of 4 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Monashee Investment Management, opening a new position worth an estimated $1.63M. The largest seller was Federated Hermes, cutting an estimated $47.2M.
- 11 institutional investors held Bionano Genomics (BNGO) as of Q4 2018, up from 8 in Q3 2018.
- Funds reported $7.14M of Bionano Genomics stock for Q4 2018, down 89% quarter-over-quarter.
- 5 funds opened new Bionano Genomics positions in Q4 2018 and 1 closed out, a net change of +4 holders.
- The largest Bionano Genomics buyer in Q4 2018 was Monashee Investment Management, an estimated $1.63M added.
- The largest Bionano Genomics seller in Q4 2018 was Federated Hermes, an estimated $47.2M sold.
Based on aggregated 13F filings for Q4 2018.